Assessment using the Beck Anxiety Inventory (BAI) and Centre for Epidemiologic Studies Depression scale (CESD) showed no evidence of APOE genotype disclosure resulting in adverse psychological outcomes [194]. This evidence concerns the gene APOE and major depressive disorder.